294 related articles for article (PubMed ID: 17270077)
1. Characterization of the bulk properties of pharmaceutical solids using nonlinear optics--a review.
Lee CJ; Strachan CJ; Manson PJ; Rades T
J Pharm Pharmacol; 2007 Feb; 59(2):241-50. PubMed ID: 17270077
[TBL] [Abstract][Full Text] [Related]
2. Process analytical technology and compensating for nonlinear effects in process spectroscopic data for improved process monitoring and control.
Chen Z; Morris J
Biotechnol J; 2009 May; 4(5):610-9. PubMed ID: 19452463
[TBL] [Abstract][Full Text] [Related]
3. Analysis of solid-state transformations of pharmaceutical compounds using vibrational spectroscopy.
Heinz A; Strachan CJ; Gordon KC; Rades T
J Pharm Pharmacol; 2009 Aug; 61(8):971-88. PubMed ID: 19703341
[TBL] [Abstract][Full Text] [Related]
4. Perspectives in the use of spectroscopy to characterise pharmaceutical solids.
Aaltonen J; Gordon KC; Strachan CJ; Rades T
Int J Pharm; 2008 Dec; 364(2):159-69. PubMed ID: 18555625
[TBL] [Abstract][Full Text] [Related]
5. Growth and spectroscopic characterization of a new organic nonlinear optical crystal: L-alaninium succinate.
Raja CR; Gokila G; Joseph AA
Spectrochim Acta A Mol Biomol Spectrosc; 2009 May; 72(4):753-6. PubMed ID: 19157964
[TBL] [Abstract][Full Text] [Related]
6. Recent Advances in Nonlinear Optical Analyses of Pharmaceutical Materials in the Solid State.
Schmitt PD
Mol Pharm; 2017 Mar; 14(3):555-565. PubMed ID: 28125239
[TBL] [Abstract][Full Text] [Related]
7. Achieving polymorph selectivity in the crystallization of pharmaceutical solids: basic considerations and recent advances.
Reutzel-Edens SM
Curr Opin Drug Discov Devel; 2006 Nov; 9(6):806-15. PubMed ID: 17117688
[TBL] [Abstract][Full Text] [Related]
8. Terahertz pulsed spectroscopy and imaging in the pharmaceutical setting--a review.
Zeitler JA; Taday PF; Newnham DA; Pepper M; Gordon KC; Rades T
J Pharm Pharmacol; 2007 Feb; 59(2):209-23. PubMed ID: 17270075
[TBL] [Abstract][Full Text] [Related]
9. Towards characterization and identification of solid state pharmaceutical mixtures through second harmonic generation.
Rawle CB; Lee CJ; Strachan CJ; Payne K; Manson PJ; Rades T
J Pharm Sci; 2006 Apr; 95(4):761-8. PubMed ID: 16498571
[TBL] [Abstract][Full Text] [Related]
10. Improving drug manufacturing with process analytical technology.
Rodrigues LO; Alves TP; Cardoso JP; Menezes JC
IDrugs; 2006 Jan; 9(1):44-8. PubMed ID: 16374733
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, growth, structural, spectroscopic and optical studies of a new semiorganic nonlinear optical crystal: L-valine hydrochloride.
Kirubavathi K; Selvaraju K; Valluvan R; Vijayan N; Kumararaman S
Spectrochim Acta A Mol Biomol Spectrosc; 2008 Apr; 69(4):1283-6. PubMed ID: 17870657
[TBL] [Abstract][Full Text] [Related]
12. Applications of solid-state NMR to pharmaceutical polymorphism and related matters.
Harris RK
J Pharm Pharmacol; 2007 Feb; 59(2):225-39. PubMed ID: 17270076
[TBL] [Abstract][Full Text] [Related]
13. Separation processes for organic molecules using SCF Technologies.
Daintree LS; Kordikowski A; York P
Adv Drug Deliv Rev; 2008 Feb; 60(3):351-72. PubMed ID: 18006179
[TBL] [Abstract][Full Text] [Related]
14. Crystal polymorphism in chemical process development.
Lee AY; Erdemir D; Myerson AS
Annu Rev Chem Biomol Eng; 2011; 2():259-80. PubMed ID: 22432619
[TBL] [Abstract][Full Text] [Related]
15. Pharmaceutical applications of non-linear imaging.
Strachan CJ; Windbergs M; Offerhaus HL
Int J Pharm; 2011 Sep; 417(1-2):163-72. PubMed ID: 21182913
[TBL] [Abstract][Full Text] [Related]
16. Partial characterization of different mixtures of solids by measuring the optical nonlinear response.
Strachan CJ; Lee CJ; Rades T
J Pharm Sci; 2004 Mar; 93(3):733-42. PubMed ID: 14762911
[TBL] [Abstract][Full Text] [Related]
17. Nonlinear optical spectroscopy of chiral molecules.
Fischer P; Hache F
Chirality; 2005 Oct; 17(8):421-37. PubMed ID: 16082658
[TBL] [Abstract][Full Text] [Related]
18. Polymorph selection: the role of nucleation, crystal growth and molecular modeling.
Erdemir D; Lee AY; Myerson AS
Curr Opin Drug Discov Devel; 2007 Nov; 10(6):746-55. PubMed ID: 17987526
[TBL] [Abstract][Full Text] [Related]
19. Solid state amorphization of pharmaceuticals.
Willart JF; Descamps M
Mol Pharm; 2008; 5(6):905-20. PubMed ID: 18954076
[TBL] [Abstract][Full Text] [Related]
20. Supercritical fluid technologies: an innovative approach for manipulating the solid-state of pharmaceuticals.
Pasquali I; Bettini R; Giordano F
Adv Drug Deliv Rev; 2008 Feb; 60(3):399-410. PubMed ID: 17964684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
